Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugenia Quiros-Roldan

Showing results (151-160 of 209) with videos related to

Pageof 21
Sort By:
HIV Clinical Trials|July 11, 2007
Predictors of AIDS-defining events among advanced naïve patients after HAARTCarlo Torti, Giuseppe Lapadula, Franco Maggiolo, et al.
The Open AIDS Journal|August 27, 2016
Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal FunctionMaria Concetta Postorino, Eugenia Quiros-Roldan, Franco Maggiolo, et al.
Journal of Translational Medicine|April 18, 2015
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort studyElena Raffetti, Francesco Donato, Filippo Castelnuovo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trialFrancesco Mazzotta, Sergio Lo Caputo, Carlo Torti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2015
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter StudyElena Raffetti, Francesco Donato, Chiara Pezzoli, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2016
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort studyEugenia Quiros-Roldan, Elena Raffetti, Francesco Castelli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|April 21, 2022
Immunological Evolution of a Cohort of HIV-2 Infected Patients: Peculiarities of an Underestimated InfectionBenedetta Fumarola, Stefano Calza, Stefano Renzetti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 16, 2025
HIV infection among adolescents and young adults in Italy: Epidemiology, viro-immunological and treatment outcomesFrancesco Maria Fusco, Ilaria Mastrorosa, Francesca Vichi, et al.
Journal of Viral Hepatitis|February 18, 2021
The impact of DAA-mediated HCV eradication on CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation CohortAlessandra Bandera, Patrizia Lorenzini, Lucia Taramasso, et al.
BMC Infectious Diseases|March 17, 2017
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohortMaria Concetta Postorino, Mattia Prosperi, Emanuele Focà, et al.
Pageof 21

Showing results (151-160 of 209) with videos related to

Sort By:
Pageof 21
HIV Clinical Trials|July 11, 2007
Predictors of AIDS-defining events among advanced naïve patients after HAARTCarlo Torti, Giuseppe Lapadula, Franco Maggiolo, et al.
The Open AIDS Journal|August 27, 2016
Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal FunctionMaria Concetta Postorino, Eugenia Quiros-Roldan, Franco Maggiolo, et al.
Journal of Translational Medicine|April 18, 2015
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort studyElena Raffetti, Francesco Donato, Filippo Castelnuovo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trialFrancesco Mazzotta, Sergio Lo Caputo, Carlo Torti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2015
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter StudyElena Raffetti, Francesco Donato, Chiara Pezzoli, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2016
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort studyEugenia Quiros-Roldan, Elena Raffetti, Francesco Castelli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|April 21, 2022
Immunological Evolution of a Cohort of HIV-2 Infected Patients: Peculiarities of an Underestimated InfectionBenedetta Fumarola, Stefano Calza, Stefano Renzetti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 16, 2025
HIV infection among adolescents and young adults in Italy: Epidemiology, viro-immunological and treatment outcomesFrancesco Maria Fusco, Ilaria Mastrorosa, Francesca Vichi, et al.
Journal of Viral Hepatitis|February 18, 2021
The impact of DAA-mediated HCV eradication on CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation CohortAlessandra Bandera, Patrizia Lorenzini, Lucia Taramasso, et al.
BMC Infectious Diseases|March 17, 2017
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohortMaria Concetta Postorino, Mattia Prosperi, Emanuele Focà, et al.
Pageof 21